Get started
Author

Michael Benedict Subhahar

Observed names: Michael B. Subhahar, Michael Subhahar, Michael Benedict Subhahar, Subhahar, Michael Benedict
ORCID: 0000-0003-2712-0128
Observed ORCID: 0000-0003-2712-0128
OpenAlex ID: A5079348573
Identification of Hypoxia‐inducible factor (HIF) stabilizer roxadustat and its possible metabolites in thoroughbred horses for doping control
2021 · Binoy Mathew, Moses Philip, et al. · Drug Testing and Analysis · 21
Metabolic studies of hypoxia‐inducible factor stabilisers IOX2 , IOX3 and IOX4 (in vitro) for doping control
2021 · Moses Philip, Binoy Mathew, et al. · Drug Testing and Analysis · 21
In vitro studies of hypoxia inducible factor‐prolyl hydroxylase inhibitors daprodustat, desidustat, and vadadustat for equine doping control
2021 · Moses Philip, Abdul Khader Karakka Kal, et al. · Drug Testing and Analysis · 18
Detection and identification of ACP‐105 and its metabolites in equine urine using LC/MS/MS after oral administration
2020 · Michael Benedict Subhahar, Abdul Khader Karakka Kal, et al. · Drug Testing and Analysis · 14
Pharmacokinetics, metabolism and excretion of celecoxib, a selective cyclooxygenase‐2 inhibitor, in horses
2019 · Michael Benedict Subhahar, Jaipaul Singh, et al. · Journal of Veterinary Pharmacology and Therapeutics · 14
Development and validation of a chiral LC‐MS method for the enantiomeric resolution of (+) and (−)‐medetomidine in equine plasma by using polysaccharide‐based chiral stationary phases
2020 · Abdul Khader Karakka Kal, Jahfar Nalakath, et al. · Chirality · 13
Electrospray ionization mass spectrometry adduct formation by mobile phase additives: A case study using nitrile functional groups containing selective androgen receptor modulators
2023 · Tajudheen Kunhamu Karatt, Meleparappil Muhammed Ajeebsanu, et al. · Rapid Communications in Mass Spectrometry · 11
PDF
Metabolic study of hypoxia‐inducible factor stabilizers BAY 87‐2243, MK‐8617, and PT‐2385 in equine liver microsomes for doping control
2022 · Moses Philip, Abdul Khader Karakka Kal, et al. · Drug Testing and Analysis · 11
Investigation of in vitro generated metabolites of GLPG0492 using equine liver microsomes for doping control
2023 · Tajudheen K. Karatt, M. Anwar Sathiq, et al. · Drug Testing and Analysis · 10
Simultaneous analysis of 44 frequently abused corticosteroid drugs using polysaccharide‐based chiral column‐HRMS approach
2021 · Abdul Khader Karakka Kal, Tajudheen K. Karatt, et al. · Analytical Science Advances · 10
PDF
Characterization of growth hormone secretagogue small molecule ibutamoren (MK‐0677) and its possible metabolites in thoroughbred horses for doping control
2022 · Moses Philip, Abdul Khader Karakka Kal, et al. · Rapid Communications in Mass Spectrometry · 9
An extensive screening method for the identification and quantitation of ecdysteroids in equine urine and plasma using liquid chromatography coupled with mass spectrometry
2023 · Tajudheen K. Karatt, M. Anwar Sathiq, et al. · Rapid Communications in Mass Spectrometry · 7
Characterization of equine liver microsome‐generated metabolites of growth hormone secretagogue small molecule ibutamoren
2021 · Moses Philip, Abdul Khader Karakka Kal, et al. · Rapid Communications in Mass Spectrometry · 7
Using Inductively Coupled Plasma Mass Spectrometry to Assess Essential and Performance-Enhancing Metals in the Urine of Racehorses
2020 · Abdul Khader Karakka Kal, Zubair Perwad, et al. · Journal of Analytical Toxicology · 7
In‐depth metabolic study of nonsteroidal selective androgen receptor modulator GSK2881078 in thoroughbred horses and horse liver microsomes for doping control
2023 · Tajudheen K. Karatt, M. Anwar Sathiq, et al. · Drug Testing and Analysis · 6
Metabolic study of selective androgen receptor modulator LY2452473 in thoroughbred horses for doping control
2023 · Tajudheen K. Karatt, M. Anwar Sathiq, et al. · Rapid Communications in Mass Spectrometry · 6
PDF
Hydroxy levamisole and its phase II conjugates as potential indicators of levamisole doping in thoroughbred horses
2022 · Moses Philip, Abdul Khader Karakka Kal, et al. · Rapid Communications in Mass Spectrometry · 6
Suzetrigine in Equestrian Sports: Optimized Extraction and LC‐HRMS Detection Strategies
2025 · Meleparappil Muhammed Ajeebsanu, Shino Ann Koshy, et al. · Rapid Communications in Mass Spectrometry · 5
PDF
Equine metabolic investigation of the phosphodiesterase‐4 inhibitor ibudilast as a potential performance enhancer
2024 · Moses Philip, Abdul Khader Karakka Kal, et al. · Rapid Communications in Mass Spectrometry · 5
PDF
Analysis of the polymeric mixture in hypoxen, using high‐performance liquid chromatography coupled with high‐resolution mass spectrometry
2024 · Abdul Khader Karakka Kal, Michael Benedict Subhahar, et al. · Rapid Communications in Mass Spectrometry · 4
PDF
Comprehensive metabolic investigation of dopamine reuptake inhibitor HDMP‐28 in equine liver microsomes and Cunninghamella elegans for doping control
2024 · Meleparappil Muhammed Ajeebsanu, Michael Benedict Subhahar, et al. · Drug Testing and Analysis · 4
Doping control approach: Identification of equine in vitro metabolites of voxelotor (GBT440), a hemoglobin S polymerization inhibitor
2023 · Michael Benedict Subhahar, Abdul Khader Karakka Kal, et al. · Rapid Communications in Mass Spectrometry · 3
Detection and Pharmacokinetics of Etoricoxib in Thoroughbred Horses
2020 · Michael B. Subhahar, Jaipaul Singh, et al. · Journal of Equine Veterinary Science · 2
Introduction to Biological Matrices in Forensic Science
2026 · Abdul Khader Karakka Kal, Michael Benedict Subhahar, et al. · Springer eBooks · 1
Equine Metabolism of Voxelotor and Its Impact on Hematological Indices: A Doping Control Perspective
2025 · Abdul Khader Karakka Kal, Michael Benedict Subhahar, et al. · Drug Testing and Analysis · 1
Works count: 46
Citation count: 221
H-index: 10
I10-index: 10
Year
Topic
Type